Plasma Cell Leukemia — Trials

Plasma Cell Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

53 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 23
Recruiting: 16
Ph III recruiting: 1
Growth YoY: —
Industry share: 9%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06988059	A Study of CT0596 in Plasma Cell Leukemia	recruiting	Early Phase 1	27	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	Aug 1, 2025	clinicaltrials
NCT07085559	Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research	recruiting	Early Phase 1	36	Anhui Provincial HospitalOTHER_GOV	1	Jul 25, 2025	clinicaltrials